REGENXBIO
RGNX
$16.19
Share price
0.81%
Change (1 day)
-12.01%
Change (1 year)
Categories
REGENXBIO (RGNX) - Total assets
Total assets on the balance sheet as of December 2023 : $0.57 B
According to REGENXBIO's latest financial reports the company's total assets are $0.57 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
REGENXBIO - Total assets on balance sheet (from 2014 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.57 B | -31.12% |
| 2022-12-31 | $0.83 B | -25.19% |
| 2021-12-31 | $1.11 B | 57.29% |
| 2020-12-31 | $0.70 B | 42.23% |
| 2019-12-31 | $0.49 B | -8.44% |
| 2018-12-31 | $0.54 B | 173.72% |
| 2017-12-31 | $0.19 B | 15.02% |
| 2016-12-31 | $0.17 B | -21.97% |
| 2015-12-31 | $0.22 B | 6241.45% |
| 2014-12-31 | $3.49 M | 39.08% |
| 2013-12-31 | $2.51 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.25 B | -56.09% | 🇺🇸 USA |